Sort
17,828 grants matching “crispr”
Implicating novel microglial mechanisms of late-onset Alzheimer's disease with variant-to-gene mapping methods
$35,043Elizabeth Anne Burton · University Of Pennsylvania · F31 · FY2023 · AG
Extracellular Matrix Remodeling and the Control of Invasive Lobular Carcinoma Progression
$35,031Adam Wallace Olson · University Of Michigan At Ann Arbor · F31 · FY2025 · CA
Identifying critical functions of DISC1 disrupted in major mental illness
$34,996Priya Srikanth · Harvard Medical School · F30 · FY2014 · MH
The Oncogenic functions of YAP/TAZ in Renal Cell Carcinoma
$34,994Alec Thomas McIntosh · Georgetown University · F30 · FY2023 · CA
The disruption of receptor mediated endocytosis in ethanol teratogenesis
$34,994Timothy Paul Kuka · University Of Texas At Austin · F31 · FY2018 · AA
Enhancing Neuronal Reprogramming with Epigenome Editing
$34,985Joshua Black · Duke University · F31 · FY2017 · NS
Functional Interrogation of Kdm6a-Dependent Tumor Suppression during Pancreatic Cancer
$34,963Ian Paul Winters · Stanford University · F31 · FY2016 · CA
Characterization of the role of STK38 kinase in Wnt signaling and heart development
$34,954Lauren Schnitkey · Vanderbilt University · F31 · FY2025 · HL
Developing mutable barcodes for high-resolution single-cell lineage tracing
$34,908Sadie M Vanhorn · Washington University · F31 · FY2024 · HG
Xenobiotic-responsive hepatic long non-coding RNAs
$34,889David J Waxman · Boston University (Charles River Campus) · R01 · FY2023 · ES
Cytokeratin 5/Beta-catenin interaction and crosstalk in hormone regulated breast cancer stem cells
$34,880Olivia F McGinn · University Of Colorado Denver · F31 · FY2019 · CA
Cytokeratin 5/Beta-catenin interaction and crosstalk in hormone regulated breast cancer stem cells
$34,850Olivia F McGinn · University Of Colorado Denver · F31 · FY2020 · CA
Cell Engineering Shared Resource
$34,777Boris Pasche · Wake Forest University Health Sciences · P30 · FY2022 · CA
Cell Engineering Shared Resource
$34,777Boris Pasche · Wake Forest University Health Sciences · P30 · FY2023 · CA
Designing durable apoptosis-targeting therapies for acute myeloid leukemia
$34,765Kevin Hao-Yu Lin · Duke University · F30 · FY2017 · CA
Gene Therapy for the Treatment of Neurofibromatosis Type I (NF1)
$34,748Madeleine Janette Sitton · Duke University · F99 · FY2022 · CA
PROMINENT-DUKE
$34,733Christopher M Counter · Duke University · OT2 · FY2024 · CA
Metabotropic contributions to pH-sensitivity and breathing modulation by RTN chemoreceptors
$34,698Elizabeth Catherine Gonye · University Of Virginia · F31 · FY2021 · HL
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
$34,676Ian Matthew Bayles · Case Western Reserve University · F31 · FY2019 · CA
Determining the role of ASCL1 in neuroendocrine prostate cancer
$34,656Kathia E. Rodarte · Ut Southwestern Medical Center · F31 · FY2021 · CA
Molecular and Cellular Oncology Program
$34,631James V Degregori · University Of Colorado Denver · P30 · FY2025 · CA
Elucidating the role of intestinal M cells in rotavirus enteric infection, systemic dissemination, and pathogenesis
$34,623Avan Antia · Washington University · F30 · FY2024 · AI
Metabolic Recycling and Compartmentalization in Tumor Progression
$34,591Jessica Brooke Spinelli · Harvard University · F99 · FY2018 · CA
The mechanism and consequences of MCM degradation induced by CDK4/6 inhibition
$34,563Brandon Lee Mouery · Univ Of North Carolina Chapel Hill · F31 · FY2023 · CA
Elucidating mechanisms of PARP inhibitor resistance in IDH-mutant cancers
$34,522Daniel Andrãs Colon-Rios · Yale University · F30 · FY2025 · CA